XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
This analysis points to fund families that consistently stood out in index fund history, helping you recognize dominant players over time.
25,021 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Winter weather and growing data-center energy use push electricity bills higher than inflation, placing new pressure ...
U.S.-Israel strikes on Iran trigger sharp market moves as Trump calls regime change, raising the stakes for investors...
Bitcoin prices retreat toward $60,000 while the Fear & Greed Index hits Extreme Fear. Here’s how traders assess risk,...
Oil prices jump and stock futures wobble as Middle East tensions escalate. Traders weigh what 'iran’s supreme leader ...
Today’s stock market activity shows SoFi (SOFI) directing attention as investors weigh inflation signals and higher y...
Bitcoin edged above $65,000 as oil prices slipped, but traders warn that stubborn dollar strength and elevated yields...
Investors dig into a mixed session as Amazon leads gains on Prime Day momentum and AI shopping activity. This guide b...
Retirees often rely on Social Security as a lifeline. A potential 3.8% COLA in 2027 could lift monthly checks, but th...
AI breakthroughs ignite excitement, but investors must separate hype from real value. This guide dives into how to na...
Choosing the right short-term bond ETF can feel overwhelming. This guide compares IGSB and SCHO on yield, risk, tax, ...
GTS Securities recently sold a large chunk of its XOVR exposure, shedding about 19.46 million shares worth roughly 35...